CSS
CBIO

Cubist Systematic Strategies’s Crescent Biopharma CBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-138
Closed -$3.43K – 3245
2024
Q4 		$3.43K Buy
+138
New +$3.76K ﹤0.01% 2887
2024
Q2 		– Sell
-498
Closed -$149K – 3480
2024
Q1 		$149K Buy
+498
New +$149K ﹤0.01% 3179
2023
Q2 		– Sell
-449
Closed -$56.6K – 3828
2023
Q1 		$56.6K Sell
449
-34
-7% -$7.65K ﹤0.01% 3548
2022
Q4 		$146K Buy
+483
New +$71.2K ﹤0.01% 3704
2021
Q2 		– Sell
-269
Closed -$81K – 2973
2021
Q1 		$81K Buy
269
+103
+62% +$36.9K ﹤0.01% 2680
2020
Q4 		$62K Buy
+166
New +$58.2K ﹤0.01% 2449
2018
Q4 		– Sell
-51
Closed -$74K – 2143
2018
Q3 		$74K Buy
+51
New +$77.1K ﹤0.01% 1650
2018
Q2 		– Sell
-33
Closed -$54K – 1877
2018
Q1 		$54K Buy
+33
New +$68.6K ﹤0.01% 1693

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return